These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 4178625)
1. Skin reactions in cancer chemotherapy. Silver PS Lancet; 1969 Feb; 1(7588):262-3. PubMed ID: 4178625 [No Abstract] [Full Text] [Related]
2. Maintenance of delayed hypersensitivity reactions in patients receiving cancer chemotherapy. Liebman IM; Maguire HC Acta Derm Venereol; 1968; 48(5):391-6. PubMed ID: 4177561 [No Abstract] [Full Text] [Related]
3. [Current usage of antineoplastic agents]. Niitani H Naika; 1971 Jun; 27(6):1262-9. PubMed ID: 4253731 [No Abstract] [Full Text] [Related]
4. Delayed hypersensitivity reactions in patients with breast cancer. Boeva M; Donchev T; Markova R; Christov I Neoplasma; 1978; 25(6):733-6. PubMed ID: 752118 [TBL] [Abstract][Full Text] [Related]
5. Studies on the sensitizing activity of alpha-chymotrypsin in man. Cîrstea M; Coteaţă V; Suhaciu G Physiologie; 1977; 14(2):107-12. PubMed ID: 405682 [TBL] [Abstract][Full Text] [Related]
6. Regional perfusion and circulation-stop method for chemotherapy of cancer and metastasis. Baba T; Kimura NT; Kanematsu T; Aoki K Gan; 1974 Jun; 65(3):285-7. PubMed ID: 4854067 [No Abstract] [Full Text] [Related]
7. Hyperuricaemia as an index of the response to chemotherapy in solid tumors. Wiktor-Jedrzejczak W; Siekierzynski M; Piechota W Neoplasma; 1977; 24(4):457-60. PubMed ID: 904751 [TBL] [Abstract][Full Text] [Related]
8. High-dose cyclophosphamide (NSC-26271) for recurrent or progressive ovarian adenocarcinoma. Piver MS; Barlow JJ; Chung WS Cancer Chemother Rep; 1975; 59(6):1157-8. PubMed ID: 769956 [No Abstract] [Full Text] [Related]
9. [Advantages and disadvantages of high-dosed intensive chemotherapeutic treatment of malignant tumor formations]. Bock HE; Allner R; Gross R Dtsch Med Wochenschr; 1967 Apr; 92(14):641-6. PubMed ID: 6024537 [No Abstract] [Full Text] [Related]
10. Use of chymotrypsin in dermatology. CORNBLEET T; CHESROW E Antibiotic Med Clin Ther (New York); 1959 Jan; 6(1):21-4. PubMed ID: 13628026 [No Abstract] [Full Text] [Related]
11. Advances in cancer chemotherapy. Salem PA J Med Liban; 1975; 28(1):9-24. PubMed ID: 54428 [No Abstract] [Full Text] [Related]
12. Individual cell biology: basis and prospects for a rational cancer chemotherapy. Tanneberger S Arch Geschwulstforsch; 1977; 47(8):755-65. PubMed ID: 345995 [No Abstract] [Full Text] [Related]
13. [Chemotherapy of so-called solid tumors]. Cappelaere P Sem Hop; 1971 Oct; 47(37):2203-6. PubMed ID: 4107784 [No Abstract] [Full Text] [Related]
14. The chemotherapy of cancer in children. Keidan SE Proc R Soc Med; 1966 Mar; 59(3):211-2. PubMed ID: 5909761 [No Abstract] [Full Text] [Related]
15. The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer. Jensen MB; Lænkholm AV; Nielsen TO; Eriksen JO; Wehn P; Hood T; Ram N; Buckingham W; Ferree S; Ejlertsen B Breast Cancer Res; 2018 Jul; 20(1):79. PubMed ID: 30053900 [TBL] [Abstract][Full Text] [Related]
18. Chemotherapy of neoplastic diseases in germ-free mice. Pollard M; Sharon N Mt Sinai J Med; 1974; 41(2):306-10. PubMed ID: 4544626 [No Abstract] [Full Text] [Related]
19. Oral cyclophosphamide in a case of cyclosporin and steroid-resistant chronic urticaria showing autoreactivity on autologous serum skin testing. Asero R Clin Exp Dermatol; 2005 Sep; 30(5):582-3. PubMed ID: 16045700 [No Abstract] [Full Text] [Related]
20. Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271). Cunningham TJ; Nemoto T; Rosner D; Knight E; Taylor S; Rosenbaum C; Horton J; Dao T Cancer Chemother Rep; 1974; 58(5 Pt 1):677-81. PubMed ID: 4138966 [No Abstract] [Full Text] [Related] [Next] [New Search]